| In Rs. Cr. | 202103 | 202203 | 202303 | 202403 | 202503 |
|---|---|---|---|---|---|
| Sales | 110324.03 | 12312.55 | 10569.24 | 14193.70 | 18445.53 |
| Operational Expenses+ | 69551.83 | 6641.51 | 6340.53 | 9142.70 | 11735.20 |
| Operating Profit | 40772.20 | 5671.04 | 4228.71 | 5051.00 | 6710.33 |
| Other Income | 3720.91 | 489.81 | 850.44 | 636.99 | 857.32 |
| OPM % | 36.96 | 46.06 | 40.01 | 35.59 | 36.38 |
| Depreciation and Amortisation | 6239.90 | 577.56 | 636.96 | 818.24 | 893.71 |
| Interest | 1696.63 | 121.89 | 87.23 | 96.57 | 105.26 |
| Profit Before Tax | 36556.58 | 5461.40 | 4972.98 | 4773.18 | 6568.68 |
| Tax | 9427.24 | 1406.01 | 1121.13 | 1100.08 | 2056.09 |
| Net Profit | 27129.34 | 4055.39 | 3851.85 | 3673.10 | 4512.59 |
| In Rs. Cr. | 202103 | 202203 | 202303 | 202403 | 202503 |
|---|---|---|---|---|---|
| Cash from Operating Activity+ | 27763.53 | 3329.13 | 3059.87 | 1401.51 | 4183.36 |
| Cash from Investing Activity | -19603.05 | -2054.54 | -3760.16 | -2214.59 | -1521.13 |
| Cash from Financing Activity | -6326.50 | 1806.77 | 639.73 | -771.81 | -1336.00 |
| Net Cash Flow | 1833.98 | 3081.36 | -60.56 | -1584.89 | 1326.23 |
| Opening Cash & Cash Equivalents | 2242.72 | 407.67 | 3489.03 | 3428.47 | 1843.58 |
| Closing Cash & Cash Equivalents | 4076.70 | 3489.03 | 3428.47 | 1843.58 | 3169.81 |
| In Rs. Cr. | 202103 | 202203 | 202303 | 202403 | 202503 |
|---|---|---|---|---|---|
| Assets+ | 101995.62 | 17259.28 | 21045.49 | 24767.19 | 29486.36 |
| Liabilities+ | 101995.62 | 17259.28 | 21045.49 | 24767.19 | 29486.36 |
| In % | SEP'25 | JUL'25 |
|---|---|---|
| Promoters+ | 74.69 | 74.69 |
| Public+ | 25.31 | 25.31 |
| Custodians | 0.00 | 0.00 |
| Number of Shareholders | 217681 | 825844 |
₹653.55
- 7.95 (-1.20%)
04:01 pm - close price
BSE: ANTHEM
NSE: ANTHEM
Industry: Pharmaceuticals & Drugs
House: Private